Abstract:We read with great interest the articles by Seijo and GarciaPagan, and Tripodi and Primignani recently published in Hepatology. We feel that these commentaries address an important and timely issue in patients with advanced liver disease, as they focus on the complex problem of hemostatic alterations in patients with cirrhosis, and on their possible therapeutic management. Indeed, patients with cirrhosis have a rebalanced coagulation equilibrium, although this balance is quite feeble and may be tipped either on the bleeding or on the thrombotic side by the occurrence of infections, derangement in renal function, and by the performance of invasive maneuvers. In order to correct the alterations of hematological and coagulation parameters, it is common practice among clinicians to order platelet or plasma transfusions, especially before invasive procedures. A recent survey has shown that, although patients with liver disease represented 7.7% of the inand out-patients receiving transfusions, they used 32% of administered plasma and 13% of the platelets. These findings are relevant because cirrhosis patients seldom obtain an adequate correction of thrombocytopenia with platelet transfusions and numerical improvement in prothrombin time requires transfusion of at least 2-6 units of fresh-frozen plasma. We feel that transfusing cirrhosis patients with several units of plasma to correct alteration in coagulation tests is not useful and may do harm by triggering portal hypertension-related bleeding. In fact, in 1974 Zimmon and Kessler found that the correlation between portal pressure and blood volume in cirrhosis patients was approximately linear. They demonstrated that every 100 mL of blood volume expansion, in a relatively short period of time, predicted a mean increase in portal pressure of 1.4 cm H20, equivalent to 1.03 mmHg. Using data obtained by the Holland and Brooks study, we found that to reach a target International Normalized Ratio (INR) value of 1.5 starting from various INR values (Table 1) required the transfusion of several liters of fresh-frozen plasma, and predicted an expected increase in portal pressure following transfusions that ranges from 15.5 to 25.8 mmHg. Reaching an INR target often reported as safe for invasive procedures or surgery in liver disease patients may actually paradoxically trigger bleeding. These data clearly show that research in the field of coagulation and liver disease should be fostered, and that the use of global coagulation tests such as thromboelastography should be further investigated as alternative measures in order to improve our management of patients with cirrhosis. EDOARDO G. GIANNINI, M.D., PH.D. R. TODD STRAVITZ, M.D. STEPHEN H. CALDWELL, M.D. Dipartimento di Medicina Interna Unit a di Gastroenterologia IRCCS-Azienda Ospedaliera Universitaria San Martino-IST Universit a di Genova Genova, Italy Section of Hepatology Division of Gastroenterology, Hepatology and Nutrition Hume-Lee Transplant Center Virginia Commonwealth University Richmond, VA, USA Division of Gastroenterology and Hepatology Digestive Health Center University of Virginia Charlottesville, VA, USA

S1702 Can a TEG-Based Transfusion Protocol for Acute Gastrointestinal Bleeding in Cirrhotic Patients Reduce the Utilization of Blood Products Without Elevating the Risks of Mortality and Morbidity?

Thromboelastography-guided vs. standard-of-care or on-demand platelet transfusion in patients with cirrhosis and thrombocytopenia undergoing procedures: A randomized controlled trial

Rotational Thromboelastometry Reduces the Need for Preemptive Transfusion in Cirrhosis: A Randomized Controlled Trial (NCT:05698134)

Application of thromboelastography for children undergoing cardiac surgery with cardiopulmonary bypass

Thromboelastography or rotational thromboelastometry for bleeding management in adults undergoing cardiac surgery: a systematic review with meta-analysis and trial sequential analysis.

Thromboelastography As a Tool for Monitoring Blood Coagulation Dysfunction after Adequate Fluid Resuscitation Can Predict Poor Outcomes in Patients with Septic Shock.

Regulation of Coagulation Function in Patients with Cirrhosis Splenectomy by Thromboelastography

Thromboelastography-guided blood transfusion during cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: study protocol for a prospective randomised controlled trial

Goal-directed transfusion protocol via thrombelastography in patients with abdominal trauma: a retrospective study

Thromboelastography-guided Intraoperative Platelet Transfusion in Pediatric Heart Surgery

Impact of blood transfusion on mortality and rebleeding in gastrointestinal bleeding: an 8-year cohort from a tertiary care center

The significance of thromboelastography and coagulation tests in guiding cardiac surgery patients perioperative blood transfusion

Association with Massive Transfusion

Thromboelastography may guide postoperative transfusion therapy after abdominal surgery

Global hemostasis testing thromboelastography: old technology, new applications

Effect of thromboelastography on coagulation states evaluation in patients with decompensated cirrhosis

RESTRICTIVE VERSUS LIBERAL BLOOD TRANSFUSION FOR ACUTE UPPER GASTROINTESTINAL BLEEDING (TRIGGER): PRAGMATIC, CLUSTER RANDOMISED, FEASIBILITY TRIAL

Application of thrombelastography in patients with end-stage hepatocirrhosis during liver transplantation: 27 cases report

Usefulness of Thromboelastography for Perioperative Evaluation of Hemostatic Profile in Patients with Primary Brain Tumors Undergoing Surgery

Comparison Of Conventional Coagulation Tests And Thromboelastography For Preoperatively Assessing Blood Loss And Transfusion During Orthotopic Liver Transplantation

Trial Sequence Meta-Analysis Can Reject False-Positive Result Calculated from Conventional Meta-Analysis